A letter from FDA indicated a delay on future Deeming Regulation compliance deadlines by 3 months, the reason for the extension stated in the letter is that; ” This extension will allow new leadership at the FDA and the Department of Health and Human Services additional time to more fully consider issues raised by the final rule that are now the subject of multiple lawsuits in federal court. ” We are not sure whether…
Dear Valued Aspire Customers, For those of you who are affected by FDA/TPD regulation guidelines, Aspire is working hard and making progress on both fronts. Aspire is working to meet the FDA guidelines. We have retained a lawyer are working to register products and company. We will also be completing the ingredients listings which are due February 17, 2017. As most of us know, in the USA, we will have at least two years to…
